# Cognizant Technology Solutions Corp: financial statements, quarterly

CTSH · Nasdaq · CIK 1058290 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctsh.md) · [Financials](/companies/ctsh/financials.md) · [Filings](/companies/ctsh/filings.md) · [Insiders](/companies/ctsh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctsh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,758 d](/filings/0001058290-26-000008.md) | [4,760](/filings/0001058290-25-000125.md) | [4,850](/filings/0001058290-25-000267.md) | [5,044](/filings/0001058290-25-000341.md) | [5,082 d](/filings/0001058290-26-000008.md) | [5,115](/filings/0001058290-26-000016.md) | [5,245](/filings/0001058290-26-000031.md) | [5,415](/filings/0001058290-26-000041.md) | [5,333 d](/filings/0001058290-26-000008.md) | [5,413](/filings/0001058290-26-000016.md) | [5,481](/filings/0001058290-26-000031.md) | [5,664](/filings/0001058290-26-000041.md) |
| Selling, general and administrative | $m | [786 d](/filings/0001058290-26-000008.md) | [765](/filings/0001058290-25-000125.md) | [781](/filings/0001058290-25-000267.md) | [833](/filings/0001058290-25-000341.md) | [844 d](/filings/0001058290-26-000008.md) | [791](/filings/0001058290-26-000016.md) | [810](/filings/0001058290-26-000031.md) | [833](/filings/0001058290-26-000041.md) | [806 d](/filings/0001058290-26-000008.md) | [791](/filings/0001058290-26-000016.md) | [728](/filings/0001058290-26-000031.md) | [841](/filings/0001058290-26-000041.md) |
| Operating income | $m | [724 d](/filings/0001058290-26-000008.md) | [695](/filings/0001058290-25-000125.md) | [708](/filings/0001058290-25-000267.md) | [738](/filings/0001058290-25-000341.md) | [751 d](/filings/0001058290-26-000008.md) | [853](/filings/0001058290-26-000016.md) | [817](/filings/0001058290-26-000031.md) | [866](/filings/0001058290-26-000041.md) | [853 d](/filings/0001058290-26-000008.md) | [843](/filings/0001058290-26-000016.md) | [874](/filings/0001058290-26-000031.md) | [872](/filings/0001058290-26-000041.md) |
| Interest expense | $m | [11.0 d](/filings/0001058290-24-000017.md) | [11.0](/filings/0001058290-24-000116.md) | [10.0](/filings/0001058290-24-000242.md) | [14.0](/filings/0001058290-24-000327.md) | [19.0 d](/filings/0001058290-26-000008.md) | [12.0](/filings/0001058290-26-000016.md) | [9.0](/filings/0001058290-26-000031.md) | [8.0](/filings/0001058290-26-000041.md) | [8.0 d](/filings/0001058290-26-000008.md) | [7.0](/filings/0001058290-26-000016.md) | [13.0](/filings/0001058290-26-000031.md) | [19.0](/filings/0001058290-26-000041.md) |
| Income tax | $m | [195 d](/filings/0001058290-26-000008.md) | [179](/filings/0001058290-25-000125.md) | [165](/filings/0001058290-25-000267.md) | [170](/filings/0001058290-25-000341.md) | [199 d](/filings/0001058290-26-000008.md) | [213](/filings/0001058290-26-000016.md) | [197](/filings/0001058290-26-000031.md) | [613](/filings/0001058290-26-000041.md) | [235 d](/filings/0001058290-26-000008.md) | [208](/filings/0001058290-26-000016.md) | [231](/filings/0001058290-26-000031.md) | [237](/filings/0001058290-26-000041.md) |
| Net income | $m | [558 d](/filings/0001058290-26-000008.md) | [546](/filings/0001058290-25-000341.md) | [566](/filings/0001058290-25-000341.md) | [582](/filings/0001058290-25-000341.md) | [546 d](/filings/0001058290-26-000008.md) | [663](/filings/0001058290-26-000041.md) | [645](/filings/0001058290-26-000041.md) | [274](/filings/0001058290-26-000041.md) | [648 d](/filings/0001058290-26-000008.md) | [662](/filings/0001058290-26-000041.md) | [636](/filings/0001058290-26-000041.md) | [627](/filings/0001058290-26-000041.md) |
| Diluted EPS | $ per share | not reported | [1.10](/filings/0001058290-25-000125.md) | [1.14](/filings/0001058290-25-000267.md) | [1.17](/filings/0001058290-25-000341.md) | not reported | [1.34](/filings/0001058290-26-000016.md) | [1.31](/filings/0001058290-26-000031.md) | [0.56](/filings/0001058290-26-000041.md) | not reported | [1.39](/filings/0001058290-26-000016.md) | [1.36](/filings/0001058290-26-000031.md) | [1.39](/filings/0001058290-26-000041.md) |
| Basic EPS | $ per share | not reported | [1.10](/filings/0001058290-25-000125.md) | [1.14](/filings/0001058290-25-000267.md) | [1.17](/filings/0001058290-25-000341.md) | not reported | [1.34](/filings/0001058290-26-000016.md) | [1.31](/filings/0001058290-26-000031.md) | [0.56](/filings/0001058290-26-000041.md) | not reported | [1.39](/filings/0001058290-26-000016.md) | [1.36](/filings/0001058290-26-000031.md) | [1.39](/filings/0001058290-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.6](/filings/0001058290-25-000017.md) | [2.2](/filings/0001058290-24-000116.md) | [2.2](/filings/0001058290-24-000242.md) | [2.0](/filings/0001058290-24-000327.md) | [2.2](/filings/0001058290-26-000008.md) | [2.0](/filings/0001058290-25-000125.md) | [1.8](/filings/0001058290-25-000267.md) | [2.3](/filings/0001058290-25-000341.md) | [1.9](/filings/0001058290-26-000041.md) | [1.5](/filings/0001058290-26-000016.md) | [1.0](/filings/0001058290-26-000031.md) | [1.5](/filings/0001058290-26-000041.md) |
| Current assets | $bn | [7.5](/filings/0001058290-25-000017.md) | [7.1](/filings/0001058290-24-000116.md) | [7.2](/filings/0001058290-24-000242.md) | [7.5](/filings/0001058290-24-000327.md) | [7.5](/filings/0001058290-26-000008.md) | [7.5](/filings/0001058290-25-000125.md) | [7.6](/filings/0001058290-25-000267.md) | [8.1](/filings/0001058290-25-000341.md) | [7.8](/filings/0001058290-26-000041.md) | [7.8](/filings/0001058290-26-000016.md) | [7.6](/filings/0001058290-26-000031.md) | [8.1](/filings/0001058290-26-000041.md) |
| Total assets | $bn | [18.5](/filings/0001058290-25-000017.md) | [18.4](/filings/0001058290-24-000116.md) | [18.6](/filings/0001058290-24-000242.md) | [20.2](/filings/0001058290-24-000327.md) | [20.0](/filings/0001058290-26-000008.md) | [20.0](/filings/0001058290-25-000125.md) | [20.2](/filings/0001058290-25-000267.md) | [20.1](/filings/0001058290-25-000341.md) | [20.7](/filings/0001058290-26-000041.md) | [20.5](/filings/0001058290-26-000016.md) | [20.8](/filings/0001058290-26-000031.md) | [21.3](/filings/0001058290-26-000041.md) |
| Current liabilities | $bn | [3.3](/filings/0001058290-25-000017.md) | [3.0](/filings/0001058290-24-000116.md) | [2.9](/filings/0001058290-24-000242.md) | [3.4](/filings/0001058290-24-000327.md) | [3.6](/filings/0001058290-26-000008.md) | [3.4](/filings/0001058290-25-000125.md) | [3.2](/filings/0001058290-25-000267.md) | [3.4](/filings/0001058290-25-000341.md) | [3.7](/filings/0001058290-26-000041.md) | [3.5](/filings/0001058290-26-000016.md) | [3.5](/filings/0001058290-26-000031.md) | [3.6](/filings/0001058290-26-000041.md) |
| Total liabilities | $bn | [5.3](/filings/0001058290-25-000017.md) | [4.9](/filings/0001058290-24-000116.md) | [4.7](/filings/0001058290-24-000242.md) | [5.7](/filings/0001058290-24-000327.md) | [5.6](/filings/0001058290-26-000008.md) | [5.1](/filings/0001058290-25-000125.md) | [4.9](/filings/0001058290-25-000267.md) | [5.2](/filings/0001058290-25-000341.md) | [5.7](/filings/0001058290-26-000041.md) | [5.4](/filings/0001058290-26-000016.md) | [6.4](/filings/0001058290-26-000031.md) | [6.6](/filings/0001058290-26-000041.md) |
| Long-term debt | $bn | [0.6](/filings/0001058290-25-000017.md) | [0.6](/filings/0001058290-24-000116.md) | [0.6](/filings/0001058290-24-000242.md) | [1.2](/filings/0001058290-24-000327.md) | [0.9](/filings/0001058290-26-000008.md) | [0.6](/filings/0001058290-25-000125.md) | [0.6](/filings/0001058290-25-000267.md) | [0.6](/filings/0001058290-25-000341.md) | [0.5](/filings/0001058290-26-000041.md) | [0.5](/filings/0001058290-26-000016.md) | [1.5](/filings/0001058290-26-000031.md) | [1.6](/filings/0001058290-26-000041.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001058290-25-000017.md) | [0.0](/filings/0001058290-24-000116.md) | [0.0](/filings/0001058290-24-000242.md) | [0.0](/filings/0001058290-24-000327.md) | [0.0](/filings/0001058290-26-000008.md) | [0.0](/filings/0001058290-25-000125.md) | [0.0](/filings/0001058290-25-000267.md) | [0.0](/filings/0001058290-25-000341.md) | [0.0](/filings/0001058290-26-000041.md) | [0.0](/filings/0001058290-26-000016.md) | [0.0](/filings/0001058290-26-000031.md) | [0.0](/filings/0001058290-26-000041.md) |
| Shareholders' equity | $bn | [13.2](/filings/0001058290-26-000008.md) | [13.5](/filings/0001058290-25-000341.md) | [13.9](/filings/0001058290-25-000341.md) | [14.5](/filings/0001058290-25-000341.md) | [14.4](/filings/0001058290-26-000041.md) | [14.9](/filings/0001058290-26-000041.md) | [15.3](/filings/0001058290-26-000041.md) | [14.9](/filings/0001058290-26-000041.md) | [15.0](/filings/0001058290-26-000041.md) | [15.1](/filings/0001058290-26-000041.md) | [14.5](/filings/0001058290-26-000041.md) | [14.7](/filings/0001058290-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [737 d](/filings/0001058290-26-000008.md) | [95.0](/filings/0001058290-25-000125.md) | [262 d](/filings/0001058290-25-000267.md) | [847 d](/filings/0001058290-25-000341.md) | [920 d](/filings/0001058290-26-000008.md) | [400](/filings/0001058290-26-000016.md) | [398 d](/filings/0001058290-26-000031.md) | [1,227 d](/filings/0001058290-26-000041.md) | [858 d](/filings/0001058290-26-000008.md) | [274](/filings/0001058290-26-000016.md) | [558 d](/filings/0001058290-26-000031.md) | [1,004 d](/filings/0001058290-26-000041.md) |
| Capital expenditure | $m | [78.0 d](/filings/0001058290-26-000008.md) | [79.0](/filings/0001058290-25-000125.md) | [79.0 d](/filings/0001058290-25-000267.md) | [56.0 d](/filings/0001058290-25-000341.md) | [83.0 d](/filings/0001058290-26-000008.md) | [77.0](/filings/0001058290-26-000016.md) | [67.0 d](/filings/0001058290-26-000031.md) | [67.0 d](/filings/0001058290-26-000041.md) | [77.0 d](/filings/0001058290-26-000008.md) | [76.0](/filings/0001058290-26-000016.md) | [99.0 d](/filings/0001058290-26-000031.md) | [79.0 d](/filings/0001058290-26-000041.md) |
| Dividends paid | $m | [146 d](/filings/0001058290-26-000008.md) | [151](/filings/0001058290-25-000125.md) | [150 d](/filings/0001058290-25-000267.md) | [149 d](/filings/0001058290-25-000341.md) | [150 d](/filings/0001058290-26-000008.md) | [155](/filings/0001058290-26-000016.md) | [153 d](/filings/0001058290-26-000031.md) | [151 d](/filings/0001058290-26-000041.md) | [151 d](/filings/0001058290-26-000008.md) | [159](/filings/0001058290-26-000016.md) | [157 d](/filings/0001058290-26-000031.md) | [149 d](/filings/0001058290-26-000041.md) |
| Share repurchases | $m | [313 d](/filings/0001058290-26-000008.md) | [133](/filings/0001058290-25-000125.md) | [76.0 d](/filings/0001058290-25-000267.md) | [242 d](/filings/0001058290-25-000341.md) | [154 d](/filings/0001058290-26-000008.md) | [209](/filings/0001058290-26-000016.md) | [368 d](/filings/0001058290-26-000031.md) | [463 d](/filings/0001058290-26-000041.md) | [338 d](/filings/0001058290-26-000008.md) | [444](/filings/0001058290-26-000016.md) | [1,163 d](/filings/0001058290-26-000031.md) | [270 d](/filings/0001058290-26-000041.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [509](/filings/0001058290-24-000116.md) | [507](/filings/0001058290-24-000242.md) | [505](/filings/0001058290-24-000327.md) | [498](/filings/0001058290-25-000125.md) | [498](/filings/0001058290-25-000267.md) | [496](/filings/0001058290-25-000341.md) | [495](/filings/0001058290-26-000016.md) | [492](/filings/0001058290-26-000031.md) | [487](/filings/0001058290-26-000041.md) | [477](/filings/0001058290-26-000016.md) | [466](/filings/0001058290-26-000031.md) | [450](/filings/0001058290-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 447,030,425 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001058290-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:31 ET. No prices; not investment advice.